Month: July 2023

SAN FRANCISCO, July 18, 2023 (GLOBE NEWSWIRE) — Dolby Laboratories, Inc. (NYSE: DLB) will release financial results for the third quarter (Q3) of fiscal 2023 after the close of regular trading on Thursday, August 3, 2023. Members of Dolby management will lead a conference call open to all interested parties to discuss Q3 fiscal 2023 financial results for Dolby Laboratories at 2:00 p.m. PT (5:00 p.m. ET) on Thursday, August 3, 2023. Access to the teleconference will be available at http://investor.dolby.com or by dialing 1-888-210-2212 (+1-646-960-0390 for international callers) and entering confirmation code 5587811. A replay of the call will be available from 5:00 p.m. PT (8:00 p.m. ET) on Thursday, August 3, 2023, until 8:59 p.m. PT (11:59 p.m. ET) on Thursday, August 10, 2023, by dialing 1-800-770-2030 (+1-647-362-9199 for international...

DENVER, July 18, 2023 (GLOBE NEWSWIRE) — Black Hills Corp. (NYSE: BKH) today announced that its Colorado intrastate natural gas pipeline, Rocky Mountain Natural Gas LLC, doing business as Black Hills Energy, received approval from the Colorado Public Utility Commission of a settlement agreement for new rates to recover approximately $110 million of investments since 2017 in its 600-mile pipeline system. “We are pleased to receive approval of a settlement that supports our long-term commitments to our Colorado customers and communities to deliver safe, reliable and cleaner energy service,” said Linn Evans, president and CEO of Black Hills Corp. “This pipeline supports our ability to safely transport natural gas to various delivery points throughout western Colorado and our commitments to reduce emissions through a more resilient...

Refreshed program furthers XWELL’s transformation to meet the needs of today’s travelers NEW YORK, July 18, 2023 (GLOBE NEWSWIRE) — XWELL, Inc. (Nasdaq: XWEL) (“XWELL” or the “Company”), an authority in health and wellness solutions for people on the go, today announced its new rewards program, XWELL Rewards, for use at its airport spa brands, XpresSpa® and Treat®. While there are many options of how to spend leisure time at the airport, XWELL is giving us one more reason to choose wellness and relaxation. Plus, new XWELL Rewards members will receive 50 points for signing up and an additional 100 points on their birthday. “XWELL Rewards is yet another step in the company’s ongoing growth towards providing all-encompassing holistic wellness to our guests,” said XWELL Chief Executive Officer Scott Milford....

Vote AGAINST the Reelection of Entrenched Stratasys Board at Annual General Meeting (“AGM”) to Be Held on August 8th, 2023 Stratasys Current Board Appears Intent on Pursuing Dilutive Transaction with Desktop Metal That Would DESTROY VALUE for Stratasys Shareholders Stratasys BOARD: Historical Problematic Track Records, Subpar Performance and Questionable Reputations of Stratasys’ Entrenched, Non-Shareholder Friendly Directors To Learn More about Nano’s Vision for Stratasys and Details of Its Special Tender Offer for Stratasys Shares, visit www.StratasysValueNow.com Waltham, Mass., July 18, 2023 (GLOBE NEWSWIRE) —  Nano Dimension Ltd. (Nasdaq: NNDM, “Nano Dimension”, “Nano” or the “Company”), a leading supplier of Additively Manufactured Electronics (“AME”) and multi-dimensional polymer, metal & ceramic Additive Manufacturing...

— Focus on Gaining Access for European Patients in Remaining Geographies and Strategic Use of Commercial Resources — — Maximizes Cash Flow Opportunity Through Streamlined Model in U.S. — — Company Expects Restructuring to Drive Annual Cost Savings of Approximately $40 Million — — Announces Preliminary Earnings Results for Second Quarter 2023 — — Company to Host Conference Call Today at 5:00 p.m. EDT — DUBLIN, Ireland and BRIDGEWATER, N.J., July 18, 2023 (GLOBE NEWSWIRE) — Amarin Corporation plc (NASDAQ: AMRN) today announced that it has initiated an organizational restructuring program to right-size and strengthen the Company to enhance shareholder value. Over the last several months, the new Amarin Board of Directors and senior management team have conducted a comprehensive...

MINNEAPOLIS, July 18, 2023 (GLOBE NEWSWIRE) — Nuwellis, Inc. (Nasdaq: NUWE), a medical technology company focused on transforming the lives of people with fluid overload, announced today that its second quarter 2023 financial results will be released on Tuesday, August 8, 2023. The company will host a conference call and webcast at 9:00 AM ET, during which management will discuss the company’s financial results and provide a general business overview. To access the live webcast, please visit the Investors page of the Nuwellis website at https://ir.nuwellis.com. Alternatively, you may access the live conference call by dialing 1-833-816-1404 (U.S) or 1-412-317-0497 (international) and using the conference ID: 10180182. An audio archive of the webcast will be available following the call on the Investors page at https://ir.nuwellis.com. About...

SANTA CLARA, Calif., July 18, 2023 (GLOBE NEWSWIRE) — AMD (NASDAQ: AMD) announced today that it will report fiscal second quarter 2023 financial results on Tuesday, August 1, 2023, after the close of market. Management will conduct a conference call to discuss these results at 5:00 p.m. EDT / 2:00 p.m. PDT. Interested parties are invited to listen to the webcast of the conference call via AMD’s Investor Relations website ir.amd.com. About AMD For more than 50 years AMD has driven innovation in high-performance computing, graphics and visualization technologies. Billions of people, leading Fortune 500 businesses and cutting-edge scientific research institutions around the world rely on AMD technology daily to improve how they live, work and play. AMD employees are focused on building leadership high-performance and adaptive products...

PONTE VEDRA, Fla., July 18, 2023 (GLOBE NEWSWIRE) — Treace Medical Concepts, Inc. (“Treace”) (NasdaqGS: TMCI), a medical technology company driving a fundamental shift in the surgical treatment of hallux valgus (commonly known as bunions), today announced that it will release financial results for the second quarter of 2023 after the close of trading on Tuesday, August 8, 2023. Company management will host a conference call to discuss financial results beginning at 4:30 pm ET. Investors interested in listening to the conference call may do so by registering. Once registered, participants will receive dial-in numbers and a unique pin to join the call and ask questions. A live and archived webcast of the event will be available on the Company’s investor relations website at https://investors.treace.com/. About Treace Medical ConceptsTreace...

St. Louis, July 18, 2023 (GLOBE NEWSWIRE) — ESCO Technologies Inc. (NYSE:ESE) will report its third quarter financial results after the market close on Tuesday, August 8, 2023, followed by a conference call where the financial results and related commentary will be discussed.   Event:              Third Quarter 2023 Conference Call Date:                Tuesday, August 8Time:                4:00 p.m. Central Time The conference call webcast and an accompanying slide presentation will be available on ESCO’s investor website at https://investor.escotechnologies.com. The slide presentation will be utilized during the call and will be posted on the website prior to the call. Participants may also access the webcast using this registration link. For those unable to participate, a webcast replay will be available after the call on the...

NEW YORK, July 18, 2023 (GLOBE NEWSWIRE) — Royalty Pharma plc (Nasdaq: RPRX) today announced that it will report its second quarter 2023 financial results on Tuesday, August 8, 2023 before the U.S. financial markets open. The company will host a conference call and simultaneous webcast at 8:00 a.m. Eastern Time that day. Conference Call Information Please visit the “Investors” page of the company’s website at https://www.royaltypharma.com/investors/news-and-events/events to obtain conference call information and to view the live webcast. A replay of the conference call and webcast will be archived on the company’s website for at least 30 days. About Royalty Pharma Founded in 1996, Royalty Pharma is the largest buyer of biopharmaceutical royalties and a leading funder of innovation across the biopharmaceutical industry, collaborating...